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In the Research Review *Osteogenesis Imperfecta: Clinical Diagnosis, Nomenclature and Severity Assessment* Table [I](#ajmga36784-tbl-0001){ref-type="table-wrap"} contained a number of errors in alignment of the rows for the Gene and Protein product. The corrected Table is included here.

The online version has been updated on 19 March 2015 to include all changes.

###### 

A New OI Nomenclature Combined With Causative Genes

  OI syndrome names                                              Type                                                    Gene           MIM        Locus                                                  Protein product                              Inheritance
  -------------------------------------------------------------- ------------------------------------------------------- -------------- ---------- ------------------------------------------------------ -------------------------------------------- -------------
  A: Phenotypes with mild to moderate severity                                                                                                                                                                                                         
  Non‐deforming OI with blue sclerae                             1                                                       1\. *COL1A1*   \#166200   17q21.33                                               Collagen alpha‐1(I) chain                    AD
                                                                 2\. *COL1A2*                                            \#166200       7q22.3     Collagen alpha‐2(I) chain                              AD                                           
  Common variable OI with normal sclerae                         4                                                       1\. *COL1A1*   \#166220   17q21.33                                               Collagen alpha‐1(I) chain                    AD
                                                                 2\. *COL1A2*                                            \#166220       7q22.3     Collagen alpha‐2(I) chain                              AD                                           
                                                                 3\. *WNT1* [a](#ajmga36784-note-0001){ref-type="fn"}    \#615220       12q13.12   Wingless‐type MMTV integration site family, member 1   AD                                           
                                                                 1\. *CRTAP*                                             \#610682       3p22.3     Cartilage‐associated protein (CRTAP)                   AR                                           
                                                                 2\. *PPIB*                                              \#259440       15q22.31   Cyclophilin B (CyPB)                                   AR                                           
                                                                 3\. *SP7*                                               \#613849       12q13.13   Osterix                                                AR                                           
                                                                 1\. *PLS3*                                              \#300910       Xq23       Plastin 3                                              XL                                           
  OI with calcification in interosseous membranes                5                                                       1\. *IFITM5*   \#610967   11p15.5                                                Interferon‐induced transmembrane protein 5   AD
  B: Progressively deforming and perinatally lethal phenotypes                                                                                                                                                                                         
  Progressively deforming                                        3                                                       1\. *COL1A1*   \#259420   17q21.33                                               Collagen alpha‐1(I) chain                    AD
                                                                 2\. *COL1A2*                                            \#259420       7q22.3     Collagen alpha‐2(I) chain                              AD                                           
                                                                 1\. *BMP1*                                              \#614856       8p21.3     Bone morphogenetic protein 1                           AR                                           
                                                                 2\. *CRTAP*                                             \#610682       3p22.3     Cartilage‐associated protein (CRTAP)                   AR                                           
                                                                 3\. *FKBP10*                                            \#610968       17q21.2    Peptidyl‐prolyl cis‐transisomerase FKBP10              AR                                           
                                                                 4\. *LEPRE1*                                            \#610915       1p34.2     Prolyl 3‐hydroxylase 1 (P3H1)                          AR                                           
                                                                 5\. *PLOD2* [c](#ajmga36784-note-0003){ref-type="fn"}   \#609220       3q24       Procollagen‐lysine, 2‐oxoglutarate 5‐dioxygenase 2     AR                                           
                                                                 6\. *PPIB*                                              \#259440       15q22.31   Cyclophilin B (CyPB)                                   AR                                           
                                                                 7\. *SERPINF1*                                          \#613982       17p13.3    Pigment‐epithelium‐derived factor (PEDF)               AR                                           
                                                                 8\. *SERPINH1*                                          \#613848       11q13.5    Heat shock protein 47 (HSP47)                          AR                                           
                                                                 9\. *TMEM38B*                                           \#615066       9q31.1     Trimeric intracellular cation channel B (TRIC‐B)       AR                                           
                                                                 10\. *WNT1*                                             \#615220       12q13.12   Wingless‐type MMTV integration site family, member 1   AR                                           
                                                                 11\. *CREB3L1*                                                         11q11      Old astrocyte specifically induced substance (OASIS)   AR                                           
  Perinatally lethal OI                                          2[b](#ajmga36784-note-0002){ref-type="fn"}              1\. *COL1A1*   \#166220   17q21.33                                               Collagen alpha‐1(I) chain                    AD
                                                                 2\. *COL1A2*                                            \#166220       7q22.3     Collagen alpha‐2(I) chain                              AD                                           
                                                                 1\. *CRTAP*                                             \#610682       3p22.3     Cartilage‐associated protein (CRTAP)                   AR                                           
                                                                 2\. *LEPRE1*                                            \#610915       1p34.2     Prolyl 3‐hydroxylase 1 (P3H1)                          AR                                           
                                                                 3\. *PPIB*                                              \#259440       15q22.31   Cyclophilin B (CyPB)                                   AR                                           

So far, 12 families with AR OI due to *WNT1* mutations have been described. Developmental delay was reported in affected individuals from three families. It is uncertain whether this is part of the clinical phenotype resulting from *WNT1* mutations \[Fahiminiya et al., 2013; Keupp et al., 2013; Pyott et al., 2013\]. A dominant *WNT1* mutation appeared to cause early onset osteoporosis \[Keupp et al., 2013; Laine et al., 2013\].

In clinical practice, subdivisions OI type II‐A and OI type II‐B are still in use. OI type II‐A appears to be exclusively caused by heterozygous mutations in the *COL1A1/2* genes \[van Dijk et al., 2010\].

It has been reported that mutations in *PLOD2* may also result in progressively deforming OI \[Puig‐Hervás et al., 2012\].
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